Table 1.
Samples used for analysis
| Vaccine/falsified surrogate | Target pathogen/disease | Refs. |
|---|---|---|
| Engerix B | Hepatitis B infection | 44 |
| Flucelvax Tetra | Influenza virus strains | 45 |
| Ixiaro | Japanese encephalitis virus | 46 |
| Nimenrix | Meningococcal disease | 47 |
| Amikacin 250 mg/mL | − | 3 |
| Milli-Q water | − | 3 |
| Tap water | − | 3 |
| Water for injection | − | 3 |
| 0.9% m/V sodium chloride | − | 3,48 |
| 5% m/V glucose solution | − | 8 |
| Gentamicin 40 mg/mL | − | 48 |
| Hyaluronic acid | − | 49 |
Genuine vaccines (including target pathogen/disease) and falsified vaccine constituents (including refs.) either previously reported to have been used or could be used as falsified vaccines.